Glands and other organs: extracts of glands or other organs or of their secretions, for organo-therapeutic uses

In 2024, glands and other organs: extracts of glands or other organs or of their secretions, for organo-therapeutic uses trade exhibited significant decline, with global flows reaching $253,579,114 and a three-year compound annual growth rate of -5.8% (five-year: +0.4%). The all-time peak of $458,259,187 was recorded in 2017; the current level is 45% below that high-water mark.

Over the 30-year observation window (1995–2024), 55% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is decelerating (-5.9% acceleration).

The World Trade Flows Characterization classifies glands and other organs: extracts of glands or other organs or of their secretions, for organo-therapeutic uses as "One-way trade" in the high price range price segment, providing additional context for market positioning and competitive dynamics.

The supply side is diversified (Herfindahl-Hirschman Index 0.136). The three largest exporters — United States ($77.2M), China ($33.9M), and Denmark ($31.5M) — collectively dominate supply flows. The leading exporter has grown at -5.1% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.060). The three largest import markets are United States ($30.8M), Germany ($24.8M), and Japan ($22.8M). The largest importing market sources from 46 different supplying countries.

Estimated substitution elasticity: -57.25. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is China → Italy at $15.2M, representing 67.6% of the importer's total demand.

The volatility score for glands and other organs: extracts of glands or other organs or of their secretions, for organo-therapeutic uses is 10 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.